Ciclesonide 80 μG or 320 μG once daily achieves lung function improvement comparable with budesonide 200 μG twice daily in patients with persistent asthma

被引：0

作者：

Hansel, T ^{[1
]}

Biberger, C ^{[1
]}

Engelstätter, R ^{[1
]}

机构：

[1] Royal Brompton Hosp, London, England

来源：

THORAX | 2004年 / 59卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：71 / 71

页数：1

共 50 条

[1] Quality of life is improved by ciclesonide 160 μg once daily and budesonide 400 μg once daily in pediatric patients with persistent asthma
Verrneulen, JH
Latos, T
Müller, T
Engelstätter, R
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S184 - S184
[2] Once-daily budesonide:: 400 μg once daily is as effective as 200 μg twice daily in controlling childhood asthma
Campbell, LM
Bodalia, B
Gogbashian, CA
Gunn, SD
Humphreys, PJ
Powell, JP
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1998, 52 (04) : 213 - +
[3] Ciclesonide 160 μg once daily is as effective as budesonide 400 μg once daily in paediatric patients with persistant asthma
von Berg, A
Garcia, ML
Hellbardt, S
Bethke, TD
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S11 - S11
[4] Once-daily ciclesonide 80 or 320μg for 12 weeks is safe and effective in patients with persistent asthma
Langdon, CG
Adler, M
Mehra, S
Alexander, M
Drollmann, A
RESPIRATORY MEDICINE, 2005, 99 (10) : 1275 - 1285
[5] The Evaluation of Lung Function in Adults with Mild-to-Moderate Asthma Following Treatment with Ciclesonide 80 μg Twice Daily or 160 μg Once Daily.
Meltzer, E. O.
LaForce, C.
Korenblat, P.
Karafilidis, J.
Andrews, W.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[6] Assessment of Lung Function in Adults with Uncontrolled Mild-to-Moderate Asthma Following Treatment with Ciclesonide 80 μg Twice Daily and 160 μg Once Daily.
Berger, W. E.
Bernstein, D. I.
Andrews, W.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[7] Evaluating Pulmonary Function with Ciclesonide 80 μG Twice Daily or 160 μG Once Daily in the Morning in Patients with Mild-to-moderate Asthma Not Using an Inhaled Corticosteroid
Kerwin, E.
Andrews, W.
Pedinoff, A.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S262 - S262
[8] Efficacy and safety of once-daily ciclesonide 160 μg as compared with once-daily budesonide 400 μg in paediatric asthma patients
von Berg, A
Minic, P
Sreckovic, M
Bollrath, C
Hellbardt, S
Engelstätter, R
THORAX, 2005, 60 : II43 - II43
[9] Comparison of the efficacy and safety of ciclesonide 160 μg once daily vs. budesonide 400 μg once daily in children with asthma
von Berg, Andrea
Engelstaetter, Renate
Minic, Predrag
Sreckovic, Miodrag
Garcia Garcia, Maria Luz
Latos, Tadeusz
Vermeulen, Jan H.
Leichtl, Stefan
Hellbardt, Stefan
Bethke, Thomas D.
PEDIATRIC ALLERGY AND IMMUNOLOGY, 2007, 18 (05) : 391 - 400
[10] Comparison of ciclesonide 160μg once daily with fluticasone propionate 250μg twice daily in maintenance therapy of patients with stable asthma
Bladgen, M.
Rozen, D.
Vereecken, G.
Gruss, C.
Lawo, J.
Engelstaetter, R.
ALLERGY, 2007, 62 : 144 - 144

← 1 2 3 4 5 →